Medindia

X

Anti-Fracture Zoledronic Acid Injections Launched by Dr Reddy's in US

by Raja Nandhini on  March 7, 2013 at 9:20 AM Drug News   - G J E 4
Hyderabad based drug firm Dr Reddy's Laboratories has recently announced its launch of generic Zoledronic Acid injections in the US market.

The injection in 4 mg/5 ml strength is approved by the US Food and Drug Administration (USFDA) and is available in single use vials.
Anti-Fracture Zoledronic Acid Injections Launched by Dr Reddy's in US
Anti-Fracture Zoledronic Acid Injections Launched by Dr Reddy's in US
Advertisement

The drug, which is a bioequivalent generic version of Novartis AG's (NVS) Zometa, is used along with anti-cancer drugs to prevent bone fractures in patients with multiple myeloma and prostate cancer and for treating osteoporosis.

Advertisement
This has hiked the values of the firm's share by nearly 1.06%.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All